This report covers the present scenario and growth prospects of the global anatomic pathology testing market for 2017-2021 (base year: 2017; end year: 2021). To calculate the market size, we consider the revenue generated from the sales of various anatomic testing products such as instruments and imaging systems and consumables used for the detection of disease screening and diagnosis. The report does not include any service revenue. The market sizing is performed by calculating only the anatomic pathology testing products and not by services.

PART 01: Executive summary 6

PART 02: Scope of the report 18

Market overview 18

Top-vendor offerings 19

PART 03: Market research methodology 21

Research methodology 21

Economic indicators 22

PART 04: Introduction 23

Key market highlights 23

PART 05: Market landscape 26

Market overview 26

Market size and forecast 28

Five forces analysis 31

PART 06: Market segmentation by products 32

Instruments and imaging systems 32

Consumables and accessories 35

PART 07: Market segmentation by application 38

Breast cancer 39

Lung cancer 39

Colorectal cancer 40

Lymphoma 40

Cervical cancer 40

Prostate cancer 40

Other diseases 41

PART 08: Market segmentation by end-user 42

Hospitals 42

Clinical diagnostic laboratories 43

Physicians’ office laboratories 44

PART 09: Geographical segmentation 46

Anatomic pathology testing market in Americas 46

Anatomic pathology testing market in EMEA 51

Anatomic pathology testing market in APAC 55

PART 10: Market drivers 60

Growing prevalence of cancer in demographics 60

Use of biomarkers for disease diagnosis and increasing

efficiency 63

Paradigm shift toward precision diagnosis through

personalized medicine 64

PART 11: Impact of drivers 67

PART 12: Market challenges 68

Insurance coverage and reimbursement issues 68

Limitations of closed systems 68

High initial investment and maintenance cost 69

PART 13: Impact of drivers and challenges 70

PART 14: Market trends 71

Presence of venture capitalists in market 71

Ready-to-use reagents 72

Business strategies to increase market

competitiveness 73

PART 15: Vendor landscape 75

Competitive landscape analysis 75

PART 16: Key vendor analysis 77

Abbott Diagnostics 77

Agilent Technologies 79

Danaher 82

Roche Diagnostics 85

Thermo Fisher Scientific 88

Other prominent vendors 91

PART 17: Appendix 93

List of abbreviations 93

PART 18: Explore Technavio 94